Article
Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease
30 Jun 2006
Abstract excerpt
BACKGROUND: Fabry disease is an X-linked genetic disorder resulting in the accumulation of glycosphingolipids in various organs, leading to exercise intolerance and early mortality. Enzyme replacement therapy (ERT) has recently been approved for use in Fabry patients. GOALS OF STUDY: To assess baseline cardiopulmonary exercise characteristics in both invasive and noninvasive tests and to study the impact of ERT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
